Neuropeptide FF increases M2 activation and self-renewal of adipose tissue macrophages

The quantity and activation state of adipose tissue macrophages (ATMs) impact the development of obesity-induced metabolic diseases. Appetite-controlling hormones play key roles in obesity; however, our understanding of their effects on ATMs is limited. Here, we have shown that human and mouse ATMs express NPFFR2, a receptor for the appetite-reducing neuropeptide FF (NPFF), and that NPFFR2 expression is upregulated by IL-4, an M2-polarizing cytokine. Plasma levels of NPFF decreased in obese patients and high-fat diet–fed mice and increased following caloric restriction. NPFF promoted M2 activation and increased the proliferation of murine and human ATMs. Both M2 activation and increased ATM proliferation were abolished in NPFFR2-deficient ATMs. Mechanistically, the effects of NPFF involved the suppression of E3 ubiquitin ligase RNF128 expression, resulting in enhanced stability of phosphorylated STAT6 and increased transcription of the M2 macrophage–associated genes IL-4 receptor &agr; (Il4ra), arginase 1 (Arg1), IL-10 (Il10), and alkylglycerol monooxygenase (Agmo). NPFF induced ATM proliferation concomitantly with the increase in N-Myc downstream-regulated gene 2 (Ndrg2) expression and suppressed the transcription of Ifi200 cell-cycle inhibitor family members and MAF bZIP transcription factor B (Mafb), a negative regulator of macrophage proliferation. NPFF thus plays an important role in supporting healthy adipose tissue via the maintenance of metabolically beneficial ATMs.

[1]  Shizuka Sato,et al.  Cyclic AMP signaling enhances lipopolysaccharide sensitivity and interleukin‐33 production in RAW264.7 macrophages , 2016, Microbiology and immunology.

[2]  F. Bihel,et al.  RF-amide neuropeptides and their receptors in Mammals: Pharmacological properties, drug development and main physiological functions. , 2016, Pharmacology & therapeutics.

[3]  R. Stienstra,et al.  Adipose tissue macrophages: going off track during obesity , 2016, Diabetologia.

[4]  N. Hacohen,et al.  Lineage-specific enhancers activate self-renewal genes in macrophages and embryonic stem cells , 2016, Science.

[5]  O. Kozawa,et al.  cAMP/PKA enhances interleukin-1β-induced interleukin-6 synthesis through STAT3 in glial cells. , 2016, Cellular signalling.

[6]  W. Cao,et al.  CD11b regulates obesity-induced insulin resistance via limiting alternative activation and proliferation of adipose tissue macrophages , 2015, Proceedings of the National Academy of Sciences.

[7]  H. Yao,et al.  miR-142-5p and miR-130a-3p are regulated by IL-4 and IL-13 and control profibrogenic macrophage program , 2015, Nature Communications.

[8]  A. Russell,et al.  NDRG2 promotes myoblast proliferation and caspase 3/7 activities during differentiation, and attenuates hydrogen peroxide – But not palmitate-induced toxicity , 2015, FEBS open bio.

[9]  T. Rőszer,et al.  Understanding the Mysterious M2 Macrophage through Activation Markers and Effector Mechanisms , 2015, Mediators of inflammation.

[10]  Jong-Woo Sohn.  Network of hypothalamic neurons that control appetite , 2015, BMB reports.

[11]  G. Golderer,et al.  Tetrahydrobiopterin and alkylglycerol monooxygenase substantially alter the murine macrophage lipidome , 2015, Proceedings of the National Academy of Sciences.

[12]  J. Redondo,et al.  Retinoid X receptors orchestrate osteoclast differentiation and postnatal bone remodeling. , 2015, The Journal of clinical investigation.

[13]  R. Nurieva,et al.  Grail controls Th2 cell development by targeting STAT6 for degradation , 2014, Nature Communications.

[14]  Bruce M. Spiegelman,et al.  What We Talk About When We Talk About Fat , 2014, Cell.

[15]  Jessica L. Cohen,et al.  Local proliferation of macrophages contributes to obesity-associated adipose tissue inflammation. , 2014, Cell metabolism.

[16]  N. He,et al.  The anti-inflammatory potential of neuropeptide FF in vitro and in vivo , 2013, Peptides.

[17]  Takao Shimizu,et al.  Alkylglycerol monooxygenase as a potential modulator for PAF synthesis in macrophages. , 2013, Biochemical and Biophysical Research Communications - BBRC.

[18]  J. Jhamandas,et al.  Role of neuropeptide FF in central cardiovascular and neuroendocrine regulation , 2013, Front. Endocrin..

[19]  Simon Yu,et al.  INTERFEROME v2.0: an updated database of annotated interferon-regulated genes , 2012, Nucleic Acids Res..

[20]  S. Hunt,et al.  Polymorphisms in the NPY2R Gene Show Significant Associations With BMI That Are Additive to FTO, MC4R, and NPFFR2 Gene Effects , 2011, Obesity.

[21]  G. Natoli,et al.  Transcriptional regulation of macrophage polarization: enabling diversity with identity , 2011, Nature Reviews Immunology.

[22]  F. Finkelman,et al.  Local Macrophage Proliferation, Rather than Recruitment from the Blood, Is a Signature of TH2 Inflammation , 2011, Science.

[23]  Martina I. Lefterova,et al.  Autoimmune Kidney Disease and Impaired Engulfment of Apoptotic Cells in Mice with Macrophage Peroxisome Proliferator-Activated Receptor γ or Retinoid X Receptor α Deficiency , 2011, The Journal of Immunology.

[24]  K. Sakamoto,et al.  The Role of the Transcription Factor CREB in Immune Function , 2010, The Journal of Immunology.

[25]  J. Lim,et al.  NDRG2-mediated Modulation of SOCS3 and STAT3 Activity Inhibits IL-10 Production , 2010, Immune network.

[26]  P. Arner,et al.  Effects of pain controlling neuropeptides on human fat cell lipolysis , 2010, International Journal of Obesity.

[27]  M. Sieweke,et al.  MafB/c-Maf Deficiency Enables Self-Renewal of Differentiated Functional Macrophages , 2009, Science.

[28]  Ke Zhang,et al.  Mndal, a new interferon-inducible family member, is highly polymorphic, suppresses cell growth, and may modify plasmacytoma susceptibility. , 2009, Blood.

[29]  L. Salazar-Olivo,et al.  RFamide neuropeptides inhibit murine and human adipose differentiation. , 2008, Biochemical and biophysical research communications.

[30]  P. Lengyel,et al.  p204, a p200 family protein, as a multifunctional regulator of cell proliferation and differentiation. , 2008, Cytokine & growth factor reviews.

[31]  D. Choubey,et al.  Interferon-inducible Ifi200-family genes in systemic lupus erythematosus. , 2008, Immunology letters.

[32]  G. Mouchiroud,et al.  The biological role of interferon-inducible P204 protein in the development of the mononuclear phagocyte system. , 2008, Frontiers in bioscience : a journal and virtual library.

[33]  A. Saltiel,et al.  Obesity induces a phenotypic switch in adipose tissue macrophage polarization. , 2007, The Journal of clinical investigation.

[34]  Alberto Mantovani,et al.  Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression1 , 2006, The Journal of Immunology.

[35]  M. Parmentier,et al.  RF9, a potent and selective neuropeptide FF receptor antagonist, prevents opioid-induced tolerance associated with hyperalgesia. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[36]  G. Mouchiroud,et al.  The interferon‐inducible gene, Ifi204, is transcriptionally activated in response to M‐CSF, and its expression favors macrophage differentiation in myeloid progenitor cells , 2006, Journal of leukocyte biology.

[37]  Justin,et al.  RF 9 , a potent and selective neuropeptide FF receptor antagonist , prevents opioid-induced tolerance associated with hyperalgesia , 2006 .

[38]  Yi Fan,et al.  IFN-γ Activates cAMP/PKA/CREB Signaling Pathway in Murine Peritoneal Macrophages , 2004 .

[39]  K. Asadullah,et al.  Molecular mechanisms of interleukin‐10‐mediated inhibition of NF‐κB activity: a role for p50 , 2004, Clinical and experimental immunology.

[40]  Yi Fan,et al.  IFN-gamma activates cAMP/PKA/CREB signaling pathway in murine peritoneal macrophages. , 2004, Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research.

[41]  M. Desai,et al.  Obesity is associated with macrophage accumulation in adipose tissue. , 2003, The Journal of clinical investigation.

[42]  A. Keegan,et al.  Regulation of the Dephosphorylation of Stat6 , 2002, The Journal of Biological Chemistry.

[43]  B. Monsarrat,et al.  Identification of neuropeptide FF‐related peptides in human cerebrospinal fluid by mass spectrometry , 2002, FEBS letters.

[44]  N. Elshourbagy,et al.  Neuropeptide AF and FF Modulation of Adipocyte Metabolism , 2002, The Journal of Biological Chemistry.

[45]  B. Borowsky,et al.  Identification and Characterization of Two G Protein-coupled Receptors for Neuropeptide FF* , 2000, The Journal of Biological Chemistry.

[46]  E. Kalso,et al.  Neuropeptide FF-Like Immunoreactivity in Human Cerebrospinal Fluid of Chronic Pain Patients and Healthy Controls , 1997, Peptides.

[47]  H. Arima,et al.  Neuropeptide FF reduces food intake in rats , 1996, Peptides.

[48]  P. Panula,et al.  Neuropeptide FF-like immunoreactivity in human plasma , 1995, Peptides.